Almac wins prestigious Aer Lingus Viscount Award for Overall Excellence
March 8, 2010
Accolade is formal recognition of Almac’s considerable contribution to sustaining economic ties between the UK and Ireland
Almac, the Craigavon based, international integrated contract development and manufacturing organization, has received the Aer Lingus Viscount Award for Overall Excellence.
The award is given annually for providing an outstanding contribution to the Northern Irish economy and improving business relationships between the UK and Ireland.
Aer Lingus, in association with UTV and Business Eye, chose Almac in recognition of the company’s enhancement of the Northern Irish knowledge economy and for its continued growth in highly competitive global markets.
Almac a strong and stable player in the international pharmaceutical market has been able to demonstrate a continuous and growing presence in Ireland, and internationally, despite turbulent economic conditions and the worst global recession for nearly 70-years.
The judging panel was made up of Tracy Meharg, Managing Director of the Innovation & Capability Group at Invest NI, Ann McGregor, Chief Executive of the Northern Ireland Chamber of Commerce, Jamie Delargy, Business Editor at UTV, Richard Buckley, Editor of Business Eye and Enda Corneille, Corporate Affairs Director at Aer Lingus.
Commenting on the announcement, Almac’s CEO, Alan Armstrong, said: “We are tremendously proud of what Almac has achieved over the last 30-years and the company’s Northern Irish roots. This award is testament to the excellence we have achieved across all divisions of our business, and in particular, the excellent team we have built – which has enabled Almac to grow into the successful company that it is today. “
For further information contact:
De Facto Communications
330 High Holborn
London WC1V 7QD
T: +44 (0)207 861 3838
About Almac Group:
Almac is a financially stable, privately owned organisation with over 30 years experience. It provides integrated development solutions to over 600 customers worldwide including all the world leaders in the pharmaceutical and biotechnology sectors. Their services include R&D, translational genomic services; API manufacture; formulation and analytical development; clinical trial supply and technology (IVRS/IWRS/ePRO) and commercial-scale manufacture and packaging.
The company has over 2,600 employees and is headquartered in Craigavon, Northern Ireland, where it was awarded “Business of the Year 2009”. US operations are based in Pennsylvania, North Carolina and California. Construction of the company’s new $120m North American Headquarters in PA started in July 2008 and will be completed in 2010.